Iberoherb

Bitter Candytuft Fresh Plant Extract, the active ingredient in Iberoherb, is a herbal extract presented as an oral preparation for oral use. Together with Matricaria liquid extract, Menthae Piperitae folium and Melissae, it forms a multi‑herb composition traditionally employed to support digestive comfort, mild gastrointestinal discomfort and occasional functional stomach upset in adult patients.

GNH USA supplies Iberoherb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide. The company adheres to EU GMP standards and provides regulatory documentation on request.

Iberoherb is a herbal combination used to address mild functional gastrointestinal disturbances. - Indigestion: helps relieve occasional dyspepsia and a feeling of fullness. - Flatulence: reduces abdominal bloating and gas accumulation. - Mild stomach cramps: eases discomfort associated with intermittent cramping. - Nausea: supports reduction of mild, transient nausea.

Iberoherb is generally well tolerated, but adverse reactions may occur.

Common Side Effects: - Mild gastrointestinal upset: transient nausea or stomach discomfort. - Taste alteration: unusual after‑taste during oral intake. - Allergic skin reaction: localized rash or itching. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Significant hypotension: rare drop in blood pressure causing dizziness. - Hepatic injury: very rare cases of liver enzyme elevation.

Consider the following precautions when using Iberoherb. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if benefits outweigh potential risks. - Known allergy: avoid if hypersensitive to any listed botanical ingredients. - Anticoagulant therapy: monitor for increased bleeding tendency. - Store at room temperature: keep in the original container, protect from moisture and light.

Potential drug interactions should be reviewed before initiating Iberoherb.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: concurrent use may increase risk of hypertensive events. - Strong CYP450 inhibitors: may theoretically raise exposure to certain herbal constituents.

Moderate Interactions (Monitor Closely): - Anticoagulant therapy: may enhance anticoagulant effect and bleeding risk. - Antidiabetic medications: possible additive hypoglycaemic effect. - Sedatives or CNS depressants: may increase drowsiness.